Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-19
    E.g., 2018-10-19

Archive Search

1 results
12:00 AM, Jul 23, 2001  |  BC Week In Review | Clinical News  |  Regulatory

MBX-102 regulatory update

Metabolex received U.S. Patent No. 6,262,118 covering the use of its MBX-102 single isomer of an …
and hyperlipidemia. The product is in Phase I testing. Metabolex Inc., Hayward, Calif.   Product: MBX-102